Updates are available Correction dated 2019-11-03

Article History

Received: 10 June 2019

Accepted: 5 September 2019

First Online: 23 September 2019

Change Date: 3 November 2019

Change Type: Correction

Change Details: ping real-world comparators for

Compliance with ethical standards

:

: Ian Chau has participated in advisory boards for AstraZeneca, Bayer, Bristol-Myers Squibb, Eli Lilly, Five Prime Therapeutics, Merck Serono, MSD, Oncologie International, Pierre Fabre, and Roche, and received honorarium and/or research funding from Eli Lilly, Janssen-Cilag, Merck Serono, and Sanofi. Dung T. Le has received research funding from, and participated in advisory boards for, Bristol-Myers Squibb and Merck Serono, and has received speaker’s honoraria from Merck Serono. Patrick A. Ott has received research funding and/or consultancy fees from Amgen, ARMO Biosciences, Array, AstraZeneca, Bristol-Myers Squibb, Celldex, CytomX, Genentech, Merck Serono, Neon Therapeutics, Novartis, and Pfizer. Beata Korytowsky, T. Kim Le, Ying Zhang, Teresa Sanchez, Melissa Laurie, Pranav Abraham, Dhiren Patel, and Tong Shangguan are employees of, and hold stock in, Bristol-Myers Squibb. Hannah Le and Gregory A. Maglinte were employed by Bristol-Myers Squibb at the time of analysis.

: Institutional Review Board approval of the study protocol was obtained prior to study conduct and included a waiver of informed consent.